InspireMD, Inc.
NSPR Real Time Price USDRecent trades of NSPR by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NSPR's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Intravascular aneurysm treatment device and methods Jul. 06, 2021
-
Patent Title: Stent assembly and methods for treatment via body lumens Mar. 02, 2021
-
Patent Title: Optimized stent jacket having single fiber mesh Sep. 10, 2019
-
Patent Title: Methods of providing optimized drug-eluting stent assemblies Sep. 10, 2019
-
Patent Title: Deformable tip for stent delivery and methods of use Apr. 16, 2019
-
Patent Title: Knitted stent jackets Nov. 27, 2018
-
Patent Title: Optimized stent jacket Sep. 11, 2018
-
Patent Title: Carotid stent apparatus and methods for treatment via body lumens Aug. 28, 2018
-
Patent Title: Stent-mesh assembly and methods Oct. 10, 2017
-
Patent Title: Stent thermoforming apparatus and methods Oct. 10, 2017
-
Patent Title: Stent thermoforming apparatus and methods Dec. 27, 2016
-
Patent Title: Optimized drug-eluting stent assembly methods Dec. 27, 2016
-
Patent Title: In vivo filter assembly Sep. 15, 2015
-
Patent Title: Optimized drug-eluting stent assembly Sep. 15, 2015
-
Patent Title: Bifurcated stent assemblies Feb. 24, 2015
-
Patent Title: In vivo filter assembly Oct. 25, 2011
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of NSPR in WallStreetBets Daily Discussion
Recent insights relating to NSPR
Recent picks made for NSPR stock on CNBC
ETFs with the largest estimated holdings in NSPR
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NSPR Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.